Klivira
Request demo

Streamlining Humana Fasenra Prior Authorization Workflows

Navigating the complexities of Humana Fasenra prior authorization is critical for timely patient access to this specialty biologic. Klivira provides the platform to streamline these intricate workflows.

Fasenra (benralizumab) is a high-volume prior authorization target, often prescribed for severe eosinophilic asthma and other conditions. For revenue cycle directors and prior authorization coordinators, understanding Humana's specific requirements, submission channels, and policy nuances is essential to minimize delays and prevent denials. This page outlines the operational considerations for securing authorization for Fasenra with Humana across commercial and Medicare Advantage plans.

Humana's Prior Authorization Channels for Fasenra

Humana employs distinct channels for medical and pharmacy benefit prior authorizations. For specialty injectables like Fasenra, the specific benefit (medical or pharmacy) dictates the submission pathway. Medical benefit submissions for Humana's Medicare Advantage and commercial plans primarily route through Availity Essentials, which serves as the central provider portal for PA initiation, eligibility verification, and document submission. Additionally, X12 278 transactions are accepted via clearinghouses for impacted procedures, offering an electronic submission option.

Specialty Pharmacy and ePA Considerations for Fasenra

When Fasenra is covered under the pharmacy benefit, Humana's in-house services, particularly CenterWell Specialty Pharmacy, manage specialty injectables and complex medications. For retail pharmacy benefit submissions, electronic prior authorization (ePA) workflows are supported via partners like CoverMyMeds and Surescripts ePA. Verifying the current ePA partner mix at each review cycle is advisable, as these arrangements can shift.

Navigating Humana's Medical Policy and Coverage Criteria

Humana publishes medical policy and coverage determination documents on its provider site. For Fasenra, precise adherence to the specific policy or coverage determination number and its effective date is paramount. For Medicare Advantage lines, which represent a significant portion of Humana's enrollment, coverage policies must align with CMS National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). It is crucial to remember that Medicare Advantage plans cannot impose prior authorization criteria more restrictive than Original Medicare's coverage rules for the same service.

Turnaround Times and CMS-0057-F Impact on Humana PA

Humana publishes precertification turnaround commitments on its provider site. For Medicare Advantage organization determinations, statutory timeframes have historically been 14 calendar days for standard pre-service decisions and 72 hours for expedited. CMS-0057-F, which applies broadly to Humana's Medicare Advantage lines as an impacted payer, tightens these to 7 calendar days for standard prior authorization decisions and 72 hours for expedited (with specific terminology for impacted-payer transaction categories). Klivira's platform helps manage these evolving compliance requirements.

Common Denial Reasons and Appeal Pathways for Fasenra with Humana

Denials for Fasenra prior authorizations from Humana are typically returned via X12 277/835 and through portal status updates. Common denial categories include medical necessity (often due to insufficient documentation), NCD/LCD non-coverage for Medicare Advantage lines, and potential step therapy or site-of-service mismatches. The appeal pathway is documented in Humana's provider manual and on its provider site. Medicare Advantage appeals follow the CMS-mandated 5-level structure, while commercial appeals follow distinct processes, with peer-to-peer reviews and expedited appeals available.

Frequently asked questions

What is the primary portal for submitting Fasenra prior authorizations to Humana?

For Fasenra prior authorizations under the medical benefit for Humana's Medicare Advantage and commercial plans, the primary portal for submission is Availity Essentials. This platform supports PA initiation, eligibility verification, and document uploads. X12 278 transactions are also accepted via clearinghouses.

How does CenterWell Specialty Pharmacy relate to Fasenra prior authorizations with Humana?

CenterWell Specialty Pharmacy (formerly Humana Pharmacy) handles specialty injectables and complex medications like Fasenra when they fall under the pharmacy benefit. If Fasenra is covered by the pharmacy benefit, CenterWell Specialty Pharmacy would be involved in its distribution and associated prior authorization processes.

Are Humana's Medicare Advantage policies for Fasenra different from Original Medicare?

Humana's Medicare Advantage coverage policies for Fasenra must align with CMS National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). Importantly, MA plans cannot impose prior authorization criteria that are more restrictive than Original Medicare's coverage rules for the same service, which is a key consideration for Fasenra authorization.

What are the typical turnaround times for Humana Fasenra prior authorizations?

Humana publishes its precertification turnaround commitments on its provider site. For Medicare Advantage, CMS-0057-F mandates 7 calendar days for standard prior authorization decisions and 72 hours for expedited decisions, which applies to Humana's MA lines. It's important to differentiate these from general organization determination timeframes.

What are common reasons for Fasenra PA denials from Humana?

Common reasons for Fasenra PA denials from Humana include insufficient documentation to prove medical necessity, non-coverage based on NCD/LCD criteria for Medicare Advantage plans, or failure to meet specific step therapy requirements if applicable. Site-of-service mismatches can also lead to denials for medical benefit drugs.

Related coverage

Other fasenra prior authorization by payer

Other fasenra prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo